Why the Global Orphan Drugs Market Is Expected to Grow at a 10.2% CAGR Through 2031
Rare diseases affect millions of people worldwide, yet many conditions continue to lack effective treatment options due to limited patient populations and complex research requirements. Increasing awareness of rare disorders, supportive government initiatives, and continuous advancements in biotechnology have significantly improved the development landscape for orphan drugs. Pharmaceutical...
0 Comments 0 Shares 57 Views 0 Reviews
Sponsored